INNOVATE-3 pivotal phase 3 randomized study

Overview of attention for article published in European Journal of Cancer (1965), February 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,611 followers.

Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study https://t.co/SHabgAxbD9 #cancer

https://t.co/ZmtkgwR3ng

Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study - European Journal of Cancer https://t.co/GHDbOG21Wz

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.